These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7920324)
1. Technetium (99mTc)-labelled white cell scanning, 51Cr-EDTA and 14C-mannitol-labelled intestinal permeability studies: non-invasive methods of diagnosing acute intestinal graft-versus-host disease. Mahendra P; Bedlow AJ; Ager S; Ancliff PJ; Wraight EP; Marcus RE Bone Marrow Transplant; 1994 Jun; 13(6):835-7. PubMed ID: 7920324 [TBL] [Abstract][Full Text] [Related]
2. Water absorption enhances the uptake of mannitol and decreases Cr-EDTA/mannitol permeability ratios in cat small intestine in situ. Bijlsma PB; Fihn BM; Sjöqvist A; Groot JA; Taminiau JA; Jodal M Scand J Gastroenterol; 2002 Jul; 37(7):799-806. PubMed ID: 12190093 [TBL] [Abstract][Full Text] [Related]
3. Stool smears for diagnosis of intestinal acute graft-versus-host disease. Hirano K; Kondo F; Kondo Y; Kurosawa K; Suwabe S; Noguchi Y; Miura N; Kakuda H; Sato T; Niimi H Bone Marrow Transplant; 1999 Oct; 24(7):799-801. PubMed ID: 10516685 [TBL] [Abstract][Full Text] [Related]
4. Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease. Neumann S; Schoppmeyer K; Lange T; Wiedmann M; Golsong J; Tannapfel A; Mossner J; Niederwieser D; Caca K Gastrointest Endosc; 2007 Mar; 65(3):403-9. PubMed ID: 17321239 [TBL] [Abstract][Full Text] [Related]
5. Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease. Nishida T; Hamaguchi M; Hirabayashi N; Haneda M; Terakura S; Atsuta Y; Imagama S; Kanie T; Murata M; Taji H; Suzuki R; Morishita Y; Kodera Y Bone Marrow Transplant; 2004 Jun; 33(11):1143-50. PubMed ID: 15077133 [TBL] [Abstract][Full Text] [Related]
6. Comparison of polysucrose 15000, 51Cr-labelled ethylenediaminetetraacetic acid, and 14C-mannitol as markers of intestinal permeability in man. Oman H; Blomquist L; Henriksson AE; Johansson SG Scand J Gastroenterol; 1995 Dec; 30(12):1172-7. PubMed ID: 9053970 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Blomquist L; Bark T; Hedenborg G; Norman A Scand J Gastroenterol; 1997 Aug; 32(8):805-12. PubMed ID: 9282973 [TBL] [Abstract][Full Text] [Related]
8. Relationship between small-intestinal transit rate and intestinal absorption of (14)C-labelled mannitol and (51)Cr-labelled ethylenediaminetetraacetic acid in healthy subjects. Madsen JL; Scharff O; Rabol A; Krogsgaard OW Scand J Gastroenterol; 1996 Mar; 31(3):254-9. PubMed ID: 8833355 [TBL] [Abstract][Full Text] [Related]
9. Is an increased intestinal permeability a valid predictor of relapse in Crohn disease? Jørgensen J; Ranløv PJ; Bjerrum PJ; Diemer H; Bisgaard K; Elsborg L Scand J Gastroenterol; 2001 May; 36(5):521-7. PubMed ID: 11346207 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of mannitol, lactulose and 51Cr-labelled ethylenediaminetetra-acetate as markers of intestinal permeability in man. Elia M; Behrens R; Northrop C; Wraight P; Neale G Clin Sci (Lond); 1987 Aug; 73(2):197-204. PubMed ID: 3115663 [TBL] [Abstract][Full Text] [Related]
11. Graft-versus-host disease following bone marrow transplantation: clinical feature and diagnosis. Kikuta A; Suzuki H Fukushima J Med Sci; 1993 Dec; 39(2):95-9. PubMed ID: 7927140 [TBL] [Abstract][Full Text] [Related]
12. Predicting the severity of intestinal graft-versus-host disease from leukotriene B4 levels after bone marrow transplantation. Takatsuka H; Yamada S; Okamoto T; Fujimori Y; Wada H; Iwata N; Kanamaru A; Kakishita E Bone Marrow Transplant; 2000 Dec; 26(12):1313-6. PubMed ID: 11223971 [TBL] [Abstract][Full Text] [Related]
13. The gut mucosa barrier is preserved during allogeneic, haemopoietic stem cell transplantation with reduced intensity conditioning. Johansson JE; Brune M; Ekman T Bone Marrow Transplant; 2001 Oct; 28(8):737-42. PubMed ID: 11781624 [TBL] [Abstract][Full Text] [Related]
14. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Jenkins RT; Jones DB; Goodacre RL; Collins SM; Coates G; Hunt RH; Bienenstock J Am J Gastroenterol; 1987 Nov; 82(11):1159-64. PubMed ID: 3118697 [TBL] [Abstract][Full Text] [Related]
15. Low percentages of circulating CD8(+)/CD45RA(+) human T lymphocytes expressing beta7 integrin correlate with the occurrence of intestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Avanzini MA; Maccario R; Locatelli F; Giebel S; Santos CD; Bernardo ME; Pagliara D; Montagna D; Longo S; Amendola G; Marconi M Exp Hematol; 2006 Oct; 34(10):1429-34. PubMed ID: 16982336 [TBL] [Abstract][Full Text] [Related]
16. Comparison between the lactulose/mannitol and 51Cr-ethylenediaminetetraacetic acid/14C-mannitol methods for intestinal permeability. Frequency distribution pattern and variability of markers and marker ratios in healthy subjects. Blomquist L; Bark T; Hedenborg G; Svenberg T; Norman A Scand J Gastroenterol; 1993 Mar; 28(3):274-80. PubMed ID: 8446853 [TBL] [Abstract][Full Text] [Related]
17. 51Cr-EDTA/14C-mannitol intestinal permeability test. Clinical use in screening for coeliac disease. Fotherby KJ; Wraight EP; Neale G Scand J Gastroenterol; 1988 Mar; 23(2):171-7. PubMed ID: 3129775 [TBL] [Abstract][Full Text] [Related]
18. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
19. Intestinal permeability compared in pediatric and adult patients with inflammatory bowel disease. Issenman RM; Jenkins RT; Radoja C Clin Invest Med; 1993 Jun; 16(3):187-96. PubMed ID: 8365046 [TBL] [Abstract][Full Text] [Related]
20. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y; Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]